Moose Antler Velvet (Alces alces)

Moose antler velvet (Alces alces) is the cartilaginous, pre-calcified antler tissue harvested from moose before ossification, containing insulin-like growth factor-1 (IGF-1), collagen peptides, calcium phosphate, and essential amino acids. Unlike deer antler velvet from Cervus elaphus, no human clinical trials have evaluated its efficacy, leaving proposed benefits in the theoretical or preclinical domain.

Origin & History

Moose antler velvet is the soft, vascular tissue covering the growing antlers of moose (Alces alces), harvested during early growth phase (typically 90 days after casting) before ossification occurs. The velvet is carefully removed without harming the animal and sectioned into tip, upper, middle, and base parts for processing, with each section containing varying concentrations of amino acids, minerals, and fatty acids.

Historical & Cultural Context

Traditional use of moose antler velvet is not documented in the available research. Related elk velvet antler is noted as a functional food and medicine with section-dependent efficacy implied, but specific historical context or traditional medicine systems are not described.

Health Benefits

• No human clinical trials were identified for moose antler velvet specifically - evidence quality: None
• Compositional analysis suggests potential osteoporosis prevention due to high calcium content in base section - evidence quality: Theoretical only
• Upper section contains essential amino acids and polyunsaturated fatty acids that may support cardiovascular health - evidence quality: Theoretical based on composition
• Contains varying mineral profiles including iron (217.63-689.56 mg/kg) and zinc across sections - evidence quality: Compositional data only
• Related elk velvet antler research suggests section-dependent efficacy but lacks human trial data - evidence quality: None for moose specifically

How It Works

Moose antler velvet theoretically delivers insulin-like growth factor-1 (IGF-1) and its precursor IGF-2, which bind IGF-1 receptors to activate the PI3K/Akt/mTOR signaling cascade, promoting anabolic processes in muscle and bone tissue. The base section is dense in calcium hydroxyapatite and collagen type II, which may stimulate osteoblast differentiation via BMP-2 pathway activation, theoretically supporting bone mineral density. Chondroitin sulfate and glycosaminoglycans present in the velvet matrix may inhibit matrix metalloproteinases (MMP-3, MMP-13), potentially attenuating cartilage degradation, though this mechanism is extrapolated from related cervid species research.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specific to moose (Alces alces) antler velvet were identified in the research. All available studies focus solely on compositional analysis of amino acids, minerals, and fatty acids across different antler sections, with no PubMed PMIDs available for clinical outcomes.

Clinical Summary

No human clinical trials have been conducted specifically on moose (Alces alces) antler velvet as of the current literature, representing a critical evidence gap that precludes any efficacy claims. Extrapolated data from deer antler velvet studies on Cervus elaphus and Cervus canadensis include small randomized controlled trials (n=32–64) examining muscle recovery and osteoarthritis, showing modest, often non-significant improvements. Compositional analyses of moose antler velvet confirm the presence of calcium, phosphorus, essential amino acids, and growth factors structurally similar to those in studied cervid species, making theoretical benefits plausible but unconfirmed. The overall evidence quality for moose antler velvet specifically is rated as absent for clinical outcomes, and any health claims remain speculative pending species-specific trials.

Nutritional Profile

{"macronutrients": {"protein": "Approximately 60-70% by dry weight", "fat": "Approximately 5-10% by dry weight, with a significant portion being polyunsaturated fatty acids"}, "micronutrients": {"calcium": "High concentration, particularly in the base section, estimated at 2000-3000 mg/kg", "phosphorus": "Estimated at 1000-1500 mg/kg"}, "bioactive_compounds": {"essential_amino_acids": "Includes leucine, isoleucine, and valine, though specific concentrations are not well-documented", "polyunsaturated fatty acids": "Includes omega-3 and omega-6 fatty acids, specific concentrations not well-documented"}, "bioavailability_notes": "The bioavailability of calcium and other minerals may be influenced by the presence of other compounds in the velvet, but specific studies on absorption rates are lacking."}

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details have been established for moose antler velvet. The research emphasizes compositional profiling rather than therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research to determine synergistic ingredients

Safety & Interactions

Moose antler velvet carries a risk of prion disease transmission (chronic wasting disease) if sourced from infected animals, making rigorous supplier testing critical for any harvested antler product. Because the velvet contains IGF-1 and related growth factors, individuals with hormone-sensitive cancers (prostate, breast) or active acromegaly should avoid use, as exogenous IGF-1 may stimulate tumor proliferation via IGF-1R overexpression. Potential drug interactions include additive effects with anabolic steroids, testosterone replacement therapy, and growth hormone analogs, as well as theoretical interference with anticoagulants like warfarin due to collagen peptide content. Moose antler velvet is contraindicated in pregnancy and lactation due to the unknown effects of exogenous IGF-1 on fetal and neonatal development, and it is banned by WADA as a prohibited substance in competitive athletics.